Kiniksa Q3 Pretax Profit Reaches $59.057 Million
Kiniksa Pharmaceuticals reported Q3 pretax profit of USD 59.057 million. The headline also reports operating expenses of USD 231.734 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.